- Home
- LFCR vs NVX Comparison
LFCR vs NVX Comparison
Compare LFCR & NVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFCR
- NVX
- Stock Information
- Founded
- LFCR 1986
- NVX 2012
- Country
- LFCR United States
- NVX Australia
- Employees
- LFCR N/A
- NVX N/A
- Industry
- LFCR Biotechnology: Pharmaceutical Preparations
- NVX Industrial Machinery/Components
- Sector
- LFCR Health Care
- NVX Miscellaneous
- Exchange
- LFCR Nasdaq
- NVX Nasdaq
- Market Cap
- LFCR 214.7M
- NVX 254.2M
- IPO Year
- LFCR N/A
- NVX N/A
- Fundamental
- Price
- LFCR $5.94
- NVX $1.47
- Analyst Decision
- LFCR Buy
- NVX Strong Buy
- Analyst Count
- LFCR 3
- NVX 1
- Target Price
- LFCR $8.00
- NVX $4.00
- AVG Volume (30 Days)
- LFCR 239.5K
- NVX 199.0K
- Earning Date
- LFCR 01-02-2025
- NVX 01-01-0001
- Dividend Yield
- LFCR N/A
- NVX N/A
- EPS Growth
- LFCR N/A
- NVX N/A
- EPS
- LFCR N/A
- NVX N/A
- Revenue
- LFCR $130,858,000.00
- NVX $6,875,112.00
- Revenue This Year
- LFCR $2.24
- NVX $89.31
- Revenue Next Year
- LFCR $7.88
- NVX $232.00
- P/E Ratio
- LFCR N/A
- NVX N/A
- Revenue Growth
- LFCR 16.47
- NVX 19.05
- 52 Week Low
- LFCR $3.68
- NVX $1.41
- 52 Week High
- LFCR $8.90
- NVX $3.10
- Technical
- Relative Strength Index (RSI)
- LFCR 37.34
- NVX 35.66
- Support Level
- LFCR $5.80
- NVX $1.45
- Resistance Level
- LFCR $6.20
- NVX $1.52
- Average True Range (ATR)
- LFCR 0.28
- NVX 0.08
- MACD
- LFCR -0.04
- NVX -0.03
- Stochastic Oscillator
- LFCR 6.40
- NVX 3.45
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.
About NVX NOVONIX Limited American Depository Shares
NOVONIX Ltd operates in the lithium-ion battery industry. The company has three operating segments namely Graphite Exploration and Mining, Battery Technology, and NOVONIX Anode Materials. Graphite Exploration and Mining segment is engaged in the exploration and development of high-grade flake graphite deposits. The NOVONIX Anode Materials segment develops and manufactures battery anode materials. The Battery Technology segment develops battery cell testing equipment and carries out research and development in battery development. The Battery Technology segment generates maximum revenue for the company.